{
"id":"mk19_bb_hm_s18",
"subspecialtyId":"hm",
"title":"Common Acquired Bleeding Disorders",
"jsonContent":{
"type":"section",
"id":"mk19_bb_hm_s18",
"title":{
"__html":"Common Acquired Bleeding Disorders"
},
"titleNode":{
"type":"section-title",
"hlId":"472f4d",
"children":[
"Common Acquired Bleeding Disorders"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_hm_s18_1",
"title":{
"__html":"Diagnosis and Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"72050b",
"children":[
"Diagnosis and Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"b6a9f0",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Liver disease:"
]
},
" Patients with liver failure have prolonged ",
{
"type":"abbreviation",
"title":"prothrombin time",
"children":[
"PT"
]
},
" and ",
{
"type":"abbreviation",
"title":"activated partial thromboplastin time",
"children":[
"aPTT"
]
},
" values owing to decreased levels of coagulation factors. Despite this, patients are not protected against thrombosis, because protein C and S levels and antithrombin levels are low as well. Fibrinogen levels are low, and the fibrinogen may be dysfunctional. Patients experiencing bleeding may require vitamin K, cryoprecipitate (increases fibrinogen), ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"fresh frozen plasma",
"children":[
"FFP"
]
},
","
]
},
" or platelets."
]
},
{
"type":"p",
"hlId":"2fa0fa",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Vitamin K deficiency:"
]
},
" Patients with liver disease and a prolonged PT require oral or IV vitamin K."
]
},
{
"type":"p",
"hlId":"df3777",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Factor inhibitors:"
]
},
" Bleeding mimics hemophilia A (most common) and B. A factor inhibitor is diagnosed with a mixing study that fails to correct the coagulation abnormality. This disorder may be associated with an underlying condition such as pregnancy, postpartum state, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"systemic lupus erythematosus",
"children":[
"SLE"
]
},
","
]
},
" or malignancy (either lymphoproliferative or solid tumor). Bleeding is treated with activated factor concentrate, and the patient should receive immunosuppression to decrease the inhibitor levels."
]
},
{
"type":"p",
"hlId":"d0bcdb",
"children":[
{
"type":"abbreviation",
"title":"disseminated intravascular coagulation",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"DIC"
]
}
]
},
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
":"
]
},
" Characteristic findings are thrombocytopenia, prolonged PT and aPTT, decreased plasma fibrinogen level, and elevated serum D-dimer. Schistocytes are seen on a peripheral blood smear. Treatment for active bleeding is platelet and coagulation factor replacement and management of the underlying disorder."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_hm_s18_inline_t1"
],
"forceOpen":true
}
]
}
]
},
"tablesContent":{
"mk19_bb_hm_s18_inline_t1":{
"id":"mk19_bb_hm_s18_inline_t1",
"number":1,
"bookId":"hm",
"title":{
"__html":"Study Table: Differential Diagnoses for Patients Experiencing Bleeding"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"18e889",
"children":[
"Study Table: Differential Diagnoses for Patients Experiencing Bleeding"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"307ffd",
"class":"col hd l",
"children":[
"Clotting Assay Abnormality"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13893f",
"class":"col hd l",
"children":[
"Differential Diagnoses"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"feec8c",
"class":"cell txt l",
"children":[
"Prolonged PT, normal aPTT"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b173ae",
"class":"cell txt l",
"children":[
"Factor VII deficiency or inhibitor"
]
},
" ",
{
"type":"p",
"hlId":"df0e20",
"class":"cell txt l",
"children":[
"DIC"
]
},
" ",
{
"type":"p",
"hlId":"21be40",
"class":"cell txt l",
"children":[
"Liver disease"
]
},
" ",
{
"type":"p",
"hlId":"0d0e12",
"class":"cell txt l",
"children":[
"Vitamin K deficiency"
]
},
" ",
{
"type":"p",
"hlId":"f5153e",
"class":"cell txt l",
"children":[
"Warfarin ingestion"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1130dd",
"class":"cell txt l",
"children":[
"Normal PT, prolonged aPTT"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f67f2",
"class":"cell txt l",
"children":[
"Deficiency of factors VIII, IX, XI, or XII"
]
},
" ",
{
"type":"p",
"hlId":"862dbc",
"class":"cell txt l",
"children":[
{
"type":"abbreviation",
"title":"von Willebrand disease",
"children":[
"vWD"
]
},
" (if severe and factor VIII level is quite low)"
]
},
" ",
{
"type":"p",
"hlId":"07f61c",
"class":"cell txt l",
"children":[
"Heparin exposure"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c9625",
"class":"cell txt l",
"children":[
"Prolonged PT and aPTT"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c764e",
"class":"cell txt l",
"children":[
"Deficiency of factors V, X, II, or fibrinogen"
]
},
" ",
{
"type":"p",
"hlId":"90b38d",
"class":"cell txt l",
"children":[
"Severe liver disease, DIC, vitamin K deficiency, or warfarin toxicity"
]
},
" ",
{
"type":"p",
"hlId":"7d1aa4",
"class":"cell txt l",
"children":[
"Heparin overdose"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0c5f0",
"class":"cell txt l",
"children":[
"Normal PT and aPTT"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"215dc5",
"class":"cell txt l",
"children":[
"Platelet dysfunction (acquired and congenital)"
]
},
" ",
{
"type":"p",
"hlId":"688955",
"class":"cell txt l",
"children":[
"vWD (if mild and factor VIII level is not too low)"
]
},
" ",
{
"type":"p",
"hlId":"ffa887",
"class":"cell txt l",
"children":[
"Scurvy"
]
},
" ",
{
"type":"p",
"hlId":"d1a700",
"class":"cell txt l",
"children":[
"Ehlers-Danlos syndrome"
]
},
" ",
{
"type":"p",
"hlId":"4ae489",
"class":"cell txt l",
"children":[
"Hereditary hemorrhagic telangiectasia"
]
},
" ",
{
"type":"p",
"hlId":"d8d949",
"class":"cell txt l",
"children":[
"Deficiency of factor XIII"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}